Perspective Therapeutics (CATX) Liabilities from Discontinued Operations (2022 - 2024)

Perspective Therapeutics' Liabilities from Discontinued Operations history spans 3 years, with the latest figure at 5070000.0 for Q1 2024.

  • On a quarterly basis, Liabilities from Discontinued Operations changed N/A to 5070000.0 in Q1 2024 year-over-year; TTM through Mar 2024 was 5070000.0, a N/A change, with the full-year FY2023 number at 5072000.0, up 1432.33% from a year prior.
  • Liabilities from Discontinued Operations hit 5070000.0 in Q1 2024 for Perspective Therapeutics, roughly flat from 5072000.0 in the prior quarter.
  • Over the last five years, Liabilities from Discontinued Operations for CATX hit a ceiling of 5072000.0 in Q4 2023 and a floor of 331000.0 in Q4 2022.
  • Historically, Liabilities from Discontinued Operations has averaged 3491000.0 across 3 years, with a median of 5070000.0 in 2024.
  • The widest YoY moves for Liabilities from Discontinued Operations: up 1432.33% in 2023, down 1432.33% in 2023.
  • Tracing CATX's Liabilities from Discontinued Operations over 3 years: stood at 331000.0 in 2022, then surged by 1432.33% to 5072000.0 in 2023, then decreased by 0.04% to 5070000.0 in 2024.
  • Business Quant data shows Liabilities from Discontinued Operations for CATX at 5070000.0 in Q1 2024, 5072000.0 in Q4 2023, and 331000.0 in Q4 2022.